Extracellular matrix-natural killer cell interactome: an uncharted territory in health and disease.

[1]  D. Beebe,et al.  Innate immune cell response to host-parasite interaction in a human intestinal tissue microphysiological system. , 2022, Science advances.

[2]  O. Mandelboim,et al.  Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT , 2022, Nature Communications.

[3]  S. Demehri,et al.  The extracellular matrix and immunity: breaking the old barrier in cancer. , 2022, Trends in immunology.

[4]  Bangmao Wang,et al.  EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model , 2022, The Journal of experimental medicine.

[5]  S. Demehri,et al.  Extracellular matrix proteins regulate NK cell function in peripheral tissues , 2022, Science advances.

[6]  M. Eckhaus,et al.  NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice , 2022, JCI insight.

[7]  S. Dakin,et al.  Interleukin-17 Cytokines and Receptors: Potential Amplifiers of Tendon Inflammation , 2021, Frontiers in Bioengineering and Biotechnology.

[8]  M. Pujana,et al.  Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion , 2021, Nature.

[9]  Nathan T. Mortimer,et al.  Extracellular matrix protein N-glycosylation mediates immune self-tolerance in Drosophila melanogaster , 2021, Proceedings of the National Academy of Sciences.

[10]  S. Ye,et al.  Extracellular Matrix Enzymes and Immune Cell Biology , 2021, Frontiers in Molecular Biosciences.

[11]  M. Colonna,et al.  The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells , 2021, Cancer Immunology Research.

[12]  B. Ludewig,et al.  Communication, construction, and fluid control: lymphoid organ fibroblastic reticular cell and conduit networks. , 2021, Trends in immunology.

[13]  Samantha M. Carlisle,et al.  Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1. , 2021, Immunity.

[14]  W. Weninger,et al.  The Extracellular Matrix in Skin Inflammation and Infection , 2021, Frontiers in Cell and Developmental Biology.

[15]  M. Karsdal,et al.  Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction , 2021, eLife.

[16]  H. Ljunggren,et al.  Natural killer cells in antiviral immunity , 2021, Nature reviews. Immunology.

[17]  J. Allison,et al.  LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy , 2021, The Journal of experimental medicine.

[18]  T. Takai,et al.  Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice. , 2021, International immunology.

[19]  G. Deniz,et al.  The Role of Natural Killer Cells in Autoimmune Diseases , 2021, Frontiers in Immunology.

[20]  Ukpong B. Eyo,et al.  Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8+ T Cells , 2021, Cancer Immunology Research.

[21]  C. Nowell,et al.  Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration. , 2021, Nanomedicine.

[22]  Jing Wang,et al.  Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion , 2020, Nature Communications.

[23]  Jianzhu Chen,et al.  CAR-NK cells: A promising cellular immunotherapy for cancer , 2020, EBioMedicine.

[24]  Hui-Hui Shen,et al.  Collagen at the maternal-fetal interface in human pregnancy , 2020, International journal of biological sciences.

[25]  K. Pogoda,et al.  Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment , 2020, bioRxiv.

[26]  R. Porrozzi,et al.  Infectious Diseases and the Lymphoid Extracellular Matrix Remodeling: A Focus on Conduit System , 2020, Cells.

[27]  Yufeng Shen,et al.  Tissue Determinants of Human NK Cell Development, Function, and Residence , 2020, Cell.

[28]  F. Souza-Fonseca-Guimaraes,et al.  Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function , 2020, Frontiers in Immunology.

[29]  Hoda Soleymani Abyaneh,et al.  Towards extracellular matrix normalization for improved treatment of solid tumors , 2020, Theranostics.

[30]  I. Sagi,et al.  Emerging roles of ECM remodeling processes in cancer. , 2020, Seminars in cancer biology.

[31]  G. Gao,et al.  Complex structure of LILRB4 and h128-3 antibody , 2019 .

[32]  P. Boor,et al.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold , 2019, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  S. Watson,et al.  LAIR-1 Limits Neutrophilic Airway Inflammation , 2019, Front. Immunol..

[34]  R. Jain,et al.  Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma , 2019, Proceedings of the National Academy of Sciences.

[35]  Amanda J. Lee,et al.  The Dual Nature of Type I and Type II Interferons , 2018, Front. Immunol..

[36]  V. V. Agashe,et al.  Leukocyte-Associated Ig-like Receptor 1 Inhibits Th1 Responses but Is Required for Natural and Induced Monocyte-Dependent Th17 Responses , 2018, The Journal of Immunology.

[37]  Daniel S. Calovi,et al.  Switching between individual and collective motility in B lymphocytes is controlled by cell-matrix adhesion and inter-cellular interactions , 2018, Scientific Reports.

[38]  Binqing Fu,et al.  Natural Killer Cells Promote Fetal Development through the Secretion of Growth‐Promoting Factors , 2017, Immunity.

[39]  Deborah S. Barkauskas,et al.  NK cell heparanase controls tumor invasion and immune surveillance , 2024, The Journal of clinical investigation.

[40]  Sarah E. Ewald,et al.  Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration , 2017, Front. Immunol..

[41]  A. Benson,et al.  A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma , 2017, The oncologist.

[42]  Brad J. Wood,et al.  Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[43]  S. A. van de Pavert,et al.  The evolution of innate lymphoid cells , 2016, Nature Immunology.

[44]  A. Theocharis,et al.  Extracellular matrix structure. , 2016, Advanced drug delivery reviews.

[45]  J. Erler,et al.  Targeting ECM Disrupts Cancer Progression , 2015, Front. Oncol..

[46]  J. Clancy,et al.  Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo , 2015, Viruses.

[47]  D. Radisky,et al.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets. , 2015, Frontiers in bioscience.

[48]  Jay D. Humphrey,et al.  Mechanotransduction and extracellular matrix homeostasis , 2014, Nature Reviews Molecular Cell Biology.

[49]  Kwang-Min Choe,et al.  Basement Membrane and Cell Integrity of Self-Tissues in Maintaining Drosophila Immunological Tolerance , 2014, PLoS genetics.

[50]  Dajin Li,et al.  Trophoblasts and Decidual Stromal Cells Regulate Decidual NK Cell Functions Via Interaction between Collagen and LAIR‐1 , 2014, American journal of reproductive immunology.

[51]  Y. Ding,et al.  The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritis. , 2014, Cellular immunology.

[52]  R. Hynes.  The evolution of metazoan extracellular matrix , 2012, The Journal of cell biology.

[53]  J. Madsen,et al.  Natural killer cells in rejection and tolerance of solid organ allografts , 2011, Current opinion in organ transplantation.

[54]  A. Theocharis,et al.  Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting , 2010, The FEBS journal.

[55]  Raghu Kalluri,et al.  Structure and Function of Basement Membranes , 2007, Experimental biology and medicine.

[56]  M. Cahalan,et al.  Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets , 2007, Proceedings of the National Academy of Sciences.

[57]  A. Sonnenberg,et al.  Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1 , 2006, The Journal of experimental medicine.

[58]  R. Colvin,et al.  The changing role of natural killer cells in solid organ rejection and tolerance. , 2006, Transplantation.

[59]  R. Kannagi,et al.  A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone* , 2004, Journal of Biological Chemistry.

[60]  R. Mecham,et al.  A Site on Laminin α5, AQARSAASKVKVSMKF, Induces Inflammatory Cell Production of Matrix Metalloproteinase-9 and Chemotaxis1 , 2003, The Journal of Immunology.

[61]  J. D. Di Santo,et al.  Interferon γ Contributes to Initiation of Uterine Vascular Modification, Decidual Integrity, and Uterine Natural Killer Cell Maturation during Normal Murine Pregnancy , 2000, The Journal of experimental medicine.

[62]  L Meyaard,et al.  LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. , 1997, Immunity.

[63]  R. Jaenisch,et al.  Skin graft rejection by beta 2-microglobulin-deficient mice , 1992, The Journal of experimental medicine.

[64]  R. Welsh,et al.  Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. , 1987, Journal of immunology.

[65]  G. Cudkowicz,et al.  DEFICIENT GROWTH OF C57BL MARROW CELLS TRANSPLANTED IN F1 HYBRID MICE. ASSOCIATION WITH THE HISTOCOMPATIBILITY-2 LOCUS. , 1964, Immunology.